Stockholders elect two Class II directors; ratify EY as auditor for FY2025

Mineralys Therapeutics, Inc.

Glenn P. Sblendorio elected with 45.4M for (85.8% of votes cast) and Derek DiRocco with 45.3M for (85.6%).
Ernst & Young ratified as independent auditor for FY2025: 59.1M for, 5.9K against, 191K abstentions.
Over 6.3M broker non-votes on director elections; none on auditor ratification.
Annual meeting held May 22, 2025; all proposals passed with requisite majority.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.